Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
Amgen
AMGN
|
$1.12B |
| 2 |
Exxon Mobil
XOM
|
$967M |
| 3 |
Alphabet (Google) Class C
GOOG
|
$945M |
| 4 |
T-Mobile US
TMUS
|
$657M |
| 5 |
American International
AIG
|
$608M |
Top Sells
| 1 |
Microsoft
MSFT
|
$2.51B |
| 2 |
Gilead Sciences
GILD
|
$1.32B |
| 3 |
DuPont de Nemours
DD
|
$1.08B |
| 4 |
General Motors
GM
|
$739M |
| 5 |
FRX
FOREST LABORATORIES INC
FRX
|
$664M |
Sector Composition
| 1 | Healthcare | 20.83% |
| 2 | Technology | 12.2% |
| 3 | Industrials | 11.56% |
| 4 | Communication Services | 11.27% |
| 5 | Consumer Discretionary | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Humana
HUM
$36.5B
| $985M | 0.36% | 9,540,959 +1,335,459 | +16% | +$138M |
|
77
CVS Health
CVS
$92.8B
| $962M | 0.36% | 13,446,652 -4,527,222 | -25% | -$324M |
|
78
Capital One
COF
$145B
| $960M | 0.36% | 12,530,000 | – | – |
|
79
Mondelez International
MDLZ
$79.5B
| $958M | 0.35% | 27,130,400 | – | – |
|
80
Boston Scientific
BSX
$156B
| $951M | 0.35% | 79,154,326 | – | – |
|
|
ENDP
81
DELISTED
Endo International plc
ENDP
| $949M | 0.35% | 14,073,200 +4,767,400 | +51% | +$322M |
|
82
Ryanair
RYAAY
$33.7B
| $938M | 0.35% | 19,980,320 +2,407,410 | +14% | +$113M |
|
|
GMCR
83
DELISTED
KEURIG GREEN MTN INC
GMCR
| $932M | 0.35% | 12,330,351 +1,790,694 | +17% | +$135M |
|
|
84
T-Mobile US
TMUS
$284B
| $905M | 0.34% | 26,907,788 +19,532,038 | +265% | +$657M |
|
85
Edwards Lifesciences
EW
$47.8B
| $903M | 0.33% | 13,738,600 -14,700 | -0.1% | -$967K |
|
86
Progressive
PGR
$145B
| $875M | 0.32% | 32,091,990 +7,513,990 | +31% | +$205M |
|
87
Zimmer Biomet
ZBH
$21B
| $865M | 0.32% | 9,277,700 +200,000 | +2% | +$18.6M |
|
88
KLA
KLAC
$115B
| $856M | 0.32% | 13,273,550 -687,649 | -5% | -$44.3M |
|
89
NRG Energy
NRG
$28.2B
| $851M | 0.32% | 29,640,828 +15,310,274 | +107% | +$440M |
|
90
United Airlines
UAL
$34B
| $845M | 0.31% | 22,342,500 +41,031 | +0.2% | +$1.55M |
|
|
RDS.A
91
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $844M | 0.31% | 11,846,407 -1,000,000 | -8% | -$71.3M |
|
92
Costco
COST
$418B
| $837M | 0.31% | 7,030,000 +675,000 | +11% | +$80.3M |
|
93
Danaher
DHR
$147B
| $816M | 0.3% | 10,565,018 +3,670 | +0% | +$283K |
|
94
TechnipFMC
FTI
$15.1B
| $805M | 0.3% | 15,413,800 | – | – |
|
95
Emerson Electric
EMR
$74.3B
| $802M | 0.3% | 11,425,980 -1,199,020 | -9% | -$84.1M |
|
|
LO
96
DELISTED
LORILLARD INC COM STK
LO
| $786M | 0.29% | 15,506,069 -12,110,655 | -44% | -$614M |
|
97
Darden Restaurants
DRI
$24.1B
| $784M | 0.29% | 14,419,500 -1,541,197 | -10% | -$83.8M |
|
98
Mattel
MAT
$5.9B
| $772M | 0.29% | 16,230,750 +188,053 | +1% | +$8.95M |
|
|
RAI
99
DELISTED
Reynolds American Inc
RAI
| $767M | 0.28% | 15,348,332 -1,983,000 | -11% | -$99.1M |
|
100
Healthpeak Properties
DOC
$12.5B
| $755M | 0.28% | 20,793,796 +2,503,500 | +14% | +$90.9M |
|